Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩221T in total. On Oct 28, 2026 the group moved up 0.68% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Stocks: 204
Total market value: ₩221T
Day's move: +0.68%
As of: Oct 28, 2026
Largest members: Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 2Q 2025

Past quarter

177 of 208 reportedOperating profit up vs a year ago: 94 of 163

Revenue+12.6%

Operating profit+98.3%

Net profit+2,052.5%

Combined, for the companies that have reported, vs the same quarter a year ago

Company	Reported	Revenue	vs a year ago	Operating profit	vs a year ago	vs last quarter	Op. margin
Samsung Biologics	Aug 14	₩1.3T	+11.5%	₩476B	+9.5%	−2.3%	36.9%37.6%
Celltrion	Aug 14	₩961B	+9.9%	₩242B	+234.5%	+62.3%	25.2%8.3%
Alteogen	Aug 13	₩19B	+52.4%	−₩426M	Smaller loss	Turned to loss	−2.3%−55.0%
SK biopharmaceuticals	Aug 14	₩176B	+31.6%	₩62B	+137.6%	+141.1%	35.1%19.4%
Yuhan	Aug 14	₩579B	+9.6%	₩50B	+168.9%	+676.7%	8.6%3.5%
HLB	Aug 13	₩16B	+6.3%	−₩23B	Smaller loss	Smaller loss	−146.6%−253.3%
Hanmi Pharm	Aug 14	₩361B	−4.5%	₩60B	+4.0%	+2.4%	16.7%15.4%
Hanmi Science	Aug 14	₩338B	+9.4%	₩35B	+30.7%	+27.9%	10.2%8.6%
SK Bioscience	Aug 12	₩162B	+504.5%	−₩37B	Bigger loss	Bigger loss	−23.1%−74.5%
PharmaResearch	Aug 14	₩141B	+69.2%	₩56B	+81.7%	+24.9%	39.7%37.0%
ABL Bio	Aug 12	₩76B	+797.2%	₩41B	Turned to profit	Turned to profit	53.8%−133.6%
Hugel	Aug 14	₩110B	+15.5%	₩57B	+33.6%	+45.5%	51.4%44.5%
Peptron	Aug 14	₩1.4B	+163.0%	−₩5B	Bigger loss	Bigger loss	−349.2%−789.3%
Voronoi	Aug 14	₩3.4B	Turned to profit	−₩10B	Bigger loss	Smaller loss	−303.3%
OliX Pharmaceuticals	Aug 14	₩6.3B	+35.9%	−₩5B	Bigger loss	Smaller loss	−79.4%−82.0%
Hanall Biopharma	Aug 14	₩41B	+28.8%	₩1.1B	Turned to profit	Turned to profit	2.8%−9.7%
D&D Pharmatech	Aug 14	₩925M	—	−₩8.1B	—	Smaller loss	−871.7%
Caregen	Aug 14	₩18B	−11.5%	₩7.4B	+20.4%	−26.8%	41.1%30.2%
Mezzion Pharma	Aug 13	₩1.7B	−23.1%	−₩3.5B	Smaller loss	Bigger loss	−203.4%−202.7%
ST Pharm	Aug 14	₩68B	+53.1%	₩13B	Turned to profit	+1,160.2%	18.9%−6.9%
Seegene	Aug 14	₩114B	+13.9%	₩3.1B	Turned to profit	−78.8%	2.8%−1.1%
GC Biopharma	Aug 14	₩500B	+19.9%	₩27B	+55.1%	+243.8%	5.5%4.2%
Naturecell	Aug 14	₩6.4B	−33.9%	−₩287M	Turned to loss	Smaller loss	−4.5%13.6%
OSCOTECInc	Aug 14	₩10B	+544.7%	−₩632M	Smaller loss	Smaller loss	−6.3%−474.3%
Kolon TissueGene	Aug 14	₩940,892	+32.4%	−₩3.9M	Smaller loss	Bigger loss	−411.8%−561.2%
Daewoong Pharma	Aug 14	₩405B	+12.5%	₩58B	+36.7%	+49.5%	14.3%11.7%
Curiox Biosystems	Aug 14	₩996M	−8.9%	−₩4B	Bigger loss	Bigger loss	−397.5%−295.5%
Chong Kun Dang Pharmaceutical	Aug 14	₩435B	+9.6%	₩24B	−34.0%	+89.9%	5.4%9.0%
JS Link	Aug 14	₩3.8B	+25.8%	−₩2.4B	Smaller loss	Smaller loss	−61.5%−78.2%
Qurient	Aug 14	₩1.8B	−7.0%	−₩6.8B	Smaller loss	Bigger loss	−366.4%−400.3%
L&C Bio	Aug 14	₩20B	+14.5%	−₩1.5M	Turned to loss	Smaller loss	−0.0%7.4%
Chabiotech	Aug 13	₩299B	+12.9%	−₩21B	Bigger loss	Bigger loss	−6.9%−0.3%
Rznomics	Aug 14	₩7.1B	—	₩3.1B	Turned to profit	Turned to profit	43.1%
G2GBIO	Aug 13	₩153M	—	−₩2.7B	—	Smaller loss	−1,789.3%
Pharmicell	Aug 13	₩27B	+50.3%	₩8.2B	+265.4%	−2.6%	30.5%12.5%
Onconic Therapeutics	Aug 11	₩9.4B	—	₩1.1B	—	−29.5%	11.8%
JW Pharmaceutical	Aug 14	₩191B	+10.9%	₩25B	+114.5%	+13.5%	13.1%6.8%
Hyundai Bioscience	Aug 14	₩333M	−96.4%	−₩4.8B	Turned to loss	Bigger loss	−1,447.4%62.0%
Medy-Tox	Aug 14	₩62B	−5.2%	₩6.3B	−55.9%	+15.4%	10.2%22.0%
BioNote	Aug 14	₩32B	+23.3%	₩6.3B	+138.3%	+35.2%	19.6%10.1%
GI Innovation	Aug 14	₩126M	Turned to profit	−₩11B	Bigger loss	Smaller loss	−8,656.5%
Shinpoong Pharmaceutical	Aug 14	₩59B	+4.6%	₩4.9B	Turned to profit	Turned to profit	8.4%−8.4%
GC	Aug 14	₩601B	+7.3%	₩22B	+104.1%	Turned to profit	3.6%1.9%
Penetrium Bioscience	Aug 14	₩2.5B	−3.9%	−₩1.7B	Smaller loss	Smaller loss	−65.4%−392.7%
AbClon	Aug 13	₩1.1B	+181.8%	−₩3.3B	Smaller loss	Smaller loss	−299.7%−932.4%
GemVax & KAEL	Aug 14	₩25B	+47.6%	−₩1.5B	Smaller loss	Smaller loss	−6.0%−18.4%
HLB Life Science	Aug 13	−₩6.3B	Turned to loss	−₩6.4B	Bigger loss	Bigger loss	—
IL Dong Pharmaceutical	Aug 14	₩138B	−9.0%	₩596M	−41.4%	−85.8%	0.4%0.7%
Curocell	Aug 13	₩0	Flat	−₩12B	Bigger loss	Bigger loss	—
Bukwang Pharmaceutical IND	Aug 14	₩43B	+15.3%	₩2B	Turned to profit	−33.2%	4.7%−5.1%
Orum Therapeutics	Aug 14	₩4.2M	—	−₩10B	—	Bigger loss	−240,123.7%
AprilBio	Aug 13	₩0	−100.0%	−₩2.7B	Turned to loss	Bigger loss	—
Medipostco	Aug 14	₩18B	+1.8%	−₩19B	Bigger loss	Bigger loss	−106.5%−52.8%
Dong-A ST	Aug 14	₩194B	+12.5%	−₩5.8B	Smaller loss	Bigger loss	−3.0%−3.5%
SillaJen	Aug 14	₩2.4B	+196.5%	−₩6.2B	Smaller loss	Bigger loss	−258.7%−829.9%
ToolGen	Aug 14	₩143M	−10.4%	−₩6.3B	Bigger loss	Bigger loss	−4,439.8%−3,786.4%
EuBiologics	Aug 13	₩36B	+360.6%	₩11B	Turned to profit	−33.5%	31.0%−20.9%
NKGen Biotech Korea	Aug 14	₩2B	−16.6%	−₩700M	Smaller loss	Bigger loss	−34.6%−111.8%
Genomictree	Aug 14	₩1.7B	+207.5%	−₩1.5B	Smaller loss	Smaller loss	−87.5%−695.9%
Q AID	Aug 14	₩23B	−18.3%	₩947M	Turned to profit	Turned to profit	4.1%−15.4%
S.Biomedics	Aug 14	₩4.8B	+45.7%	−₩2B	Bigger loss	Bigger loss	−42.6%−37.9%
FutureChem	Aug 14	₩3.6B	+6.0%	−₩1.9B	Smaller loss	Bigger loss	−52.6%−78.4%
HLB Therapeutics	Aug 14	₩16B	+34.4%	−₩666M	Smaller loss	Smaller loss	−4.2%−27.3%
IntoCell	Aug 14	₩39M	—	−₩3.7B	—	Bigger loss	−9,447.2%
Jetema	Aug 14	₩21B	+18.9%	₩1.8B	−17.6%	Turned to profit	8.6%12.4%
BioPlus	Aug 14	₩21B	+83.1%	₩2.1B	−23.8%	−70.9%	10.0%24.0%
DuChemBio	Aug 14	₩9.5B	—	₩1.9B	—	+181.8%	19.9%
Genome&Company	Aug 14	₩5.8B	−50.0%	−₩7.4B	Bigger loss	Bigger loss	−127.6%−14.7%
Binex	Aug 14	₩45B	+41.5%	₩1B	Turned to profit	+88.9%	2.3%−26.3%
3billion	Aug 14	₩2.6B	—	−₩1.6B	—	Smaller loss	−61.5%
HEM Pharma	Aug 26	₩2.8B	−3.1%	−₩2.9B	Bigger loss	Bigger loss	−102.1%−59.0%
Bioneercorporation	Aug 14	₩88B	+12.5%	₩5.3B	Turned to profit	+21.9%	6.0%−0.8%
curacle	Aug 12	—	—	−₩5.3B	Bigger loss	Bigger loss	—
Vivozon Pharmaceutical	Aug 14	₩18B	−14.7%	−₩2.7B	Turned to loss	Bigger loss	−15.3%1.7%
Kangstem Biotech	Aug 14	₩1B	−54.7%	−₩4.4B	Smaller loss	Smaller loss	−430.4%−197.7%
Helixmith	Aug 14	₩613M	−15.0%	−₩2B	Smaller loss	Smaller loss	−324.8%−821.0%
BNC Korea	Aug 14	₩25B	+8.4%	₩1.6B	−64.1%	−58.0%	6.5%19.6%
Kolon Life Science	Aug 14	₩53B	+32.2%	₩1.3B	Turned to profit	+1,598.2%	2.4%−16.0%
Eone Diagnomics Genome Center	Aug 14	−₩511M	Turned to loss	₩700M	Turned to profit	Turned to profit	—
GC Cell	Aug 14	₩43B	−5.4%	−₩3.4B	Bigger loss	Smaller loss	−7.9%−6.0%
Aptabio Therapeutics	Aug 14	₩1.1B	+0.2%	−₩4.1B	Bigger loss	Bigger loss	−368.5%−288.8%
Cellbion	Aug 13	₩404M	—	−₩2.1B	—	Bigger loss	−515.3%
ISU Abxis	Aug 14	₩23B	+59.2%	₩9.4B	+96.8%	Turned to profit	41.1%33.2%
Bio Solution	Aug 14	₩3.1B	−4.9%	−₩1.4B	Bigger loss	Bigger loss	−44.0%−21.7%
Y-Biologics	Aug 14	₩1.2B	+402.0%	−₩1.5B	Smaller loss	Smaller loss	−128.4%−1,492.5%
Aribio Holdings	Aug 14	₩9.8B	−31.1%	−₩2.8B	Bigger loss	Bigger loss	−28.6%−16.1%
Anterogen	Aug 14	₩1.9B	+10.4%	−₩455M	Smaller loss	Smaller loss	−24.1%−51.8%
Cell Biotech	Aug 14	₩12B	−5.2%	₩1.3B	−48.9%	−5.9%	10.8%20.0%
JW Shinyak	Aug 14	₩20B	−8.9%	₩2.7B	+41.6%	+300.2%	13.6%8.7%
Macrogen	Aug 14	₩49B	+62.4%	−₩1.5B	Smaller loss	Smaller loss	−3.1%−5.2%
TiumBio	Aug 14	₩2.6B	+19.5%	−₩3.5B	Smaller loss	Smaller loss	−133.7%−205.2%
Keeps Biopharma	Aug 14	₩43B	+37.6%	−₩976M	Turned to loss	Turned to loss	−2.3%9.8%
ViGenCell	Aug 14	₩622,300	−98.9%	−₩5.7B	Bigger loss	Bigger loss	−908,939.9%−6,524.6%
Celemics	Aug 13	₩1.1B	−24.8%	−₩1.3B	Bigger loss	Bigger loss	−119.5%−50.6%
HLB bioStep	Aug 13	₩18B	+49.0%	−₩4.3B	Bigger loss	Bigger loss	−24.2%−27.4%
Genexine	Aug 14	₩672M	+95.0%	−₩7.5B	Bigger loss	Smaller loss	−1,116.1%−1,995.5%
MedPacto	Aug 14	₩840M	Turned to profit	−₩2.6B	Smaller loss	Smaller loss	−304.8%
Asta	Aug 14	₩354M	−51.7%	₩36M	Turned to profit	Turned to profit	10.2%−143.3%
Metabiomed	Aug 14	₩25B	+0.6%	₩7.8B	+110.0%	+38.8%	30.6%14.7%
Aribiolab	Aug 13	—	—	−₩3.1B	Bigger loss	Bigger loss	—
CHA AI Healthkare	Aug 14	₩2B	−63.8%	−₩1.4B	Turned to loss	Smaller loss	−72.2%3.9%
DreamCIS	Aug 13	₩17B	+20.7%	₩1.5B	+166.6%	+13.9%	9.1%4.1%
iNtRON Biotechnology	Aug 14	₩1.2B	−31.0%	−₩2B	Bigger loss	Bigger loss	−159.4%−64.8%
Vaxcell-Bio Therapeutics	Aug 14	₩2B	+6,692.4%	−₩4.1B	Bigger loss	Smaller loss	−206.7%−13,387.5%
T&R Biofab	Aug 21	₩6.5B	+380.4%	−₩1.9B	Smaller loss	Smaller loss	−29.3%−307.9%
Corestemchemon	Aug 14	₩5.5B	−23.1%	−₩6.8B	Bigger loss	Bigger loss	−123.6%−85.3%
Aminologics	Aug 14	₩4.8B	−12.4%	₩216M	−18.9%	−57.8%	4.5%4.9%
HLB Global	Aug 14	₩26B	−4.7%	−₩1.1B	Turned to loss	Smaller loss	−4.3%1.4%
Enzychem Lifesciences	Aug 14	₩16B	−16.3%	−₩3.7B	Bigger loss	Bigger loss	−22.4%−18.5%
Choong ANG Vaccine Laboratory	Aug 14	₩12B	−2.0%	₩1.5B	−25.7%	−34.4%	12.5%16.4%
Pharos iBio	Aug 13	—	—	−₩2.4B	Smaller loss	Smaller loss	—
HLB Genex	Aug 14	₩10B	+9.9%	₩1.4B	+2,187.0%	+75.6%	14.3%0.7%
Polaris AI Pharma	Aug 14	₩14B	−8.1%	₩1.3B	+10.9%	+73.1%	9.2%7.6%
SCL Science	Aug 14	₩4.5B	+347.1%	−₩1.4B	Bigger loss	Bigger loss	−30.5%−96.7%
Eye Gene	Aug 14	₩877M	+56.3%	−₩2.5B	Smaller loss	Smaller loss	−279.6%−660.4%
Theragen Etex	Aug 14	₩67B	+5.3%	−₩476M	Turned to loss	Turned to loss	−0.7%5.5%
DongKook Life Science	Aug 14	₩35B	—	₩3.2B	—	+3.5%	9.2%
Choolip & Sciences	Aug 14	₩611M	+3,001.4%	−₩1.5B	Bigger loss	Smaller loss	−253.6%−7,187.0%
SunBio	Aug 14	₩1.7B	+8.2%	₩118M	Turned to profit	−90.0%	6.9%−94.3%
Sugentech	Aug 14	₩3.2B	+103.8%	−₩4.9B	Bigger loss	Bigger loss	−154.1%−310.5%
Naturalendo Tech	Aug 14	₩5.1B	−11.9%	−₩1.1B	Bigger loss	Bigger loss	−20.8%−15.7%
CTC Bio	Aug 12	₩35B	+1.7%	₩2.3B	Turned to profit	+147.5%	6.4%−1.0%
Amicogen	Aug 14	₩10B	−76.2%	−₩4.2B	Bigger loss	Smaller loss	−41.8%−4.5%
Optipharm	Aug 14	₩5.8B	+16.9%	−₩434M	Smaller loss	Smaller loss	−7.5%−16.0%
Pangen Biotech	Aug 13	₩3.5B	+53.7%	₩833M	Turned to profit	+18.8%	23.9%−5.1%
PharmGen Science	Aug 14	₩46B	+6.9%	₩3.3B	+22.0%	+62.2%	7.2%6.3%
Abion	Aug 14	₩212M	+13.7%	−₩4.4B	Smaller loss	Smaller loss	−2,055.7%−4,662.2%
Cellid	Aug 14	₩2.1B	+255.3%	−₩2.4B	Smaller loss	Smaller loss	−113.2%−540.9%
Tego Science	Aug 14	₩1.6B	−14.8%	−₩463M	Bigger loss	Smaller loss	−28.6%−7.2%
Adbiotech	Aug 14	₩2.8B	+55.2%	−₩1.9B	Bigger loss	Bigger loss	−66.3%−92.8%
HLB Panagene	Aug 14	₩3.6B	+47.7%	−₩200M	Smaller loss	Smaller loss	−5.5%−40.5%
NeoImmuneTech	Aug 14	₩17,579	Turned to profit	−₩4.8M	Smaller loss	Smaller loss	−27,107.9%
Cytogen	Aug 13	₩6.3B	+426.6%	−₩1.9B	Smaller loss	Smaller loss	−30.7%−271.9%
ENCell	Aug 14	₩1.2B	—	−₩4.5B	—	Smaller loss	−379.9%
KoBioLabs	Aug 14	₩18B	−6.7%	−₩2.8B	Bigger loss	Smaller loss	−15.9%−8.9%
Geninus	Aug 14	₩2.6B	+74.6%	−₩4B	Bigger loss	Bigger loss	−155.8%−254.5%
QuadMedicine	Aug 14	₩4.2B	—	₩34M	—	Turned to profit	0.8%
Aprogen	Aug 14	₩24B	−32.1%	−₩24B	Bigger loss	Bigger loss	−98.9%−49.6%
GeneOne Life Science	Aug 14	₩6.8B	−26.7%	−₩10B	Smaller loss	Bigger loss	−149.5%−125.9%
CJ Bioscience	Aug 14	₩784M	+0.9%	−₩7B	Smaller loss	Bigger loss	−887.2%−1,037.8%
RPbio	Aug 14	₩36B	+11.3%	₩2.3B	+379.9%	+28.8%	6.5%1.5%
Gencurix	Aug 11	₩2B	+276.3%	−₩1.3B	Smaller loss	Smaller loss	−65.5%−474.0%
Quratis	Aug 13	₩480M	+258.2%	−₩3.3B	Smaller loss	Bigger loss	−688.8%−3,723.7%
Oncocross	Aug 14	₩138M	−20.7%	−₩1.9B	Bigger loss	Smaller loss	−1,356.4%−864.9%
Wonbiogen	Aug 13	₩8.4B	+5.0%	₩1.9B	−7.6%	+23.4%	22.5%25.6%
HLB Pep	Aug 14	₩1.2B	+1.6%	−₩1.3B	Smaller loss	Smaller loss	−102.5%−132.4%
Orientbio	Aug 13	₩6.9B	+3.0%	−₩680M	Smaller loss	Smaller loss	−9.8%−10.3%
Kolmar BioTech	Aug 14	₩7.1B	−40.2%	−₩1.6B	Turned to loss	Bigger loss	−22.7%5.6%
Kainos Medicine	Aug 14	₩176M	−0.1%	−₩945M	Smaller loss	Smaller loss	−535.4%−1,778.2%
IMBdx	Aug 14	₩1.5B	+27.4%	−₩1.9B	Smaller loss	Smaller loss	−126.7%−221.7%
Eutilex	Aug 14	₩2.3B	−12.8%	−₩5.2B	Smaller loss	Bigger loss	−224.4%−203.2%
Aligned Genetics	Aug 14	₩3.9B	+20.4%	₩260M	+1.4%	−51.1%	6.6%7.9%
SeouLin Bioscience	Aug 14	₩16B	−18.0%	−₩332M	Turned to loss	Turned to loss	−2.0%1.0%
Hass	Aug 25	₩4.6B	—	₩963M	—	Turned to profit	20.9%
Biotoxtech	Aug 14	₩9.6B	−1.9%	−₩1.9B	Smaller loss	Bigger loss	−20.0%−29.6%
Genolution	Aug 14	₩2.9B	+40.1%	−₩1.7B	Smaller loss	Smaller loss	−58.8%−117.8%
Linkgenesis	Aug 13	₩3.4B	+1.5%	₩266M	−37.3%	Turned to profit	7.7%12.5%
SLSBio(Specialty Lab Solution Bio)	Aug 14	₩1.6B	−33.0%	−₩674M	Turned to loss	Bigger loss	−42.4%12.5%
LabGenomics	Aug 14	₩22B	+0.3%	−₩20B	Bigger loss	Bigger loss	−90.4%−13.1%
Genematrix	Aug 14	₩2.7B	−8.9%	−₩91M	Smaller loss	Smaller loss	−3.4%−4.9%
Dt&Cro	Aug 14	₩10B	+38.6%	−₩2B	Smaller loss	Smaller loss	−19.6%−56.1%
C&R Research	Aug 14	₩17B	+18.4%	₩1.3B	−8.8%	Turned to profit	7.4%9.7%
Shaperon	Aug 14	₩0	—	−₩3.4B	Smaller loss	Smaller loss	—
Daesung Microbiological Labs	Aug 14	₩6.7B	+19.3%	₩728M	Turned to profit	Turned to profit	10.9%−18.0%
Enbioco	Aug 13	₩8.5B	−3.5%	−₩167M	Turned to loss	Turned to loss	−2.0%8.8%
MFC	Aug 14	₩5.4B	—	₩643M	—	+501.7%	11.9%
WooGene B&Gco	Aug 14	₩14B	−4.8%	₩206M	−76.0%	−51.4%	1.5%5.9%
Xcell Therapeutics	Aug 14	₩221M	−53.7%	−₩2.7B	Bigger loss	Bigger loss	−1,203.2%−432.7%
PCL	Aug 14	₩1.7B	+385.2%	−₩4.1B	Bigger loss	Turned to loss	−247.5%−841.9%
Kbio Labs	Aug 14	₩21B	+9.3%	₩9.3M	Turned to profit	−97.3%	0.0%−0.2%
PeopleBio	Aug 14	₩733M	−46.4%	−₩2B	Smaller loss	Smaller loss	−269.6%−222.2%
Celestra	Aug 14	₩1.6B	−15.6%	−₩2.8B	Smaller loss	Smaller loss	−174.7%−210.8%
Olipass	Aug 14	₩159M	−66.5%	−₩2.3B	Smaller loss	Bigger loss	−1,450.7%−569.2%
From Bio	Aug 14	₩16B	−0.5%	−₩3.9B	Bigger loss	Bigger loss	−24.3%−23.4%
NGeneBio	Aug 14	₩1.8B	−11.1%	−₩1.9B	Smaller loss	Smaller loss	−103.5%−219.4%
BioInfra	Aug 13	₩6.1B	—	−₩1.1B	—	Smaller loss	−18.4%
Phionx	Aug 29	₩1.4M	−68.7%	−₩1.4M	Smaller loss	Smaller loss	−101.3%−68.5%
208340	Not yet
072520	Not yet
Samsung Epis Holdings	Not yet
Aimed Bio	Not yet
Ingenia Therapeutics	Not yet
Proteina	Not yet
Samyang Biopharm	Not yet
ImmuneOncia Therapeutics	Not yet
GC Genome	Not yet
Kanaph Therapeutics	Not yet
Ensol Biosciences	Not yet
Pharmaresearch Bio	Not yet
Inventera	Not yet
Imgt	Not yet
HL Genomics	Not yet
Epi Biotech	Not yet
NovMetaPharma	Not yet
Organoidsciences	Not yet
ProGen	Not yet
GFC Life Science	Not yet
Plumbline Life Sciences	Not yet
Moogene Medi	Not yet
Curachem	Not yet
Invites Biocore	Not yet
Median Diagnostics	Not yet
Medizen Humancare	Not yet
Cronex	Not yet
BioInfra Life Science	Not yet
283100	Not yet
341170	Not yet
258540	Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 28, 2026

Above 20-day average: 13.9%
Above 60-day average: 23.1%
RSI above 70: 0.6%
RSI below 30: 5.2%
52-week highs: 0
52-week lows: 8

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

0 bullish, 1 neutral, 7 bearish

Technical read

The Biotech (new drugs) theme covers 173 members, and only 13.9% of them trade above their 20-day averages while 23.1% sit above their 60-day averages. Eight members hit 52-week lows and none reached 52-week highs, with 5.2% of members showing RSI readings at the low extreme and 0.6% at the high extreme. The equal-weighted index gauge reads bearish on both short-term (7 bearish signals against 0 bullish) and medium-term (7 bearish, 0 bullish) measures, with RSI at 39.4 and the index positioned below its cloud.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK Reit SK hynix SK Networks SK Discovery SKC SK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Creators talking about this

Doctors begin to prescribe country’s first domestically developed obesity drug on Thurs.Arirang News · via YouTube

Biotech (new drugs)

+0.26%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

204 companies · 110 up · 23 flat · 71 down

Traded value: ₩702B
Value vs 20-day average: 0.75×
Top gainer: 3billion
Largest company: Samsung Biologics

Companies in this theme

Market cap Value traded Gainers Losers NPS stake

All KOSPI KOSDAQ

NPS owns > 5%

Company	Price	Daily	Traded value	Market cap	NPS
Samsung Biologics207940 · KOSPI	₩1,372,000	−0.15%	₩69B	₩64T	6.88%
Celltrion068270 · KOSPI	₩189,800	+0.64%	₩80B	₩44T	7.28%
Alteogen196170 · KOSDAQ	₩223,000	+2.06%	₩53B	₩16T	2.68%
Samsung Epis Holdings0126Z0 · KOSPI	₩316,500	+1.44%	₩9.3B	₩7.9T	5.70%
SK biopharmaceuticals326030 · KOSPI	₩75,200	+0.40%	₩8.9B	₩5.9T	6.00%
Yuhan000100 · KOSPI	₩77,300	−3.38%	₩27B	₩5.7T	6.83%
HLB028300 · KOSDAQ	₩40,650	+1.88%	₩19B	₩5.4T	1.16%
Hanmi Pharm128940 · KOSPI	₩369,500	+5.42%	₩42B	₩4.7T	9.61%
Hanmi Science008930 · KOSPI	₩41,450	+0.12%	₩11B	₩2.8T	6.27%
SK Bioscience302440 · KOSPI	₩32,150	+1.26%	₩2.2B	₩2.5T	5.50%
PharmaResearch214450 · KOSDAQ	₩228,500	−1.30%	₩44B	₩2.4T	7.14%
ABL Bio298380 · KOSDAQ	₩41,800	+2.33%	₩13B	₩2.3T	4.02%
Hugel145020 · KOSDAQ	₩181,500	+1.17%	₩4.8B	₩2.3T	2.29%
Peptron087010 · KOSDAQ	₩97,200	+1.67%	₩16B	₩2.3T	1.63%
Voronoi310210 · KOSDAQ	₩121,100	+1.94%	₩7.9B	₩2.3T	2.78%
OliX Pharmaceuticals226950 · KOSDAQ	₩97,300	+7.40%	₩22B	₩2.2T	5.04%
Hanall Biopharma009420 · KOSPI	₩38,500	+0.65%	₩7.1B	₩2T	10.56%
D&D Pharmatech347850 · KOSDAQ	₩42,900	+5.15%	₩28B	₩2T	1.75%
Caregen214370 · KOSDAQ	₩34,350	+3.15%	₩1.9B	₩1.8T	0.65%
Mezzion Pharma140410 · KOSDAQ	₩52,600	−2.41%	₩8.6B	₩1.6T	0.50%
ST Pharm237690 · KOSDAQ	₩77,200	−3.98%	₩29B	₩1.6T	5.77%
Seegene096530 · KOSDAQ	₩33,500	+2.13%	₩8.8B	₩1.6T	0.64%
GC Biopharma006280 · KOSPI	₩130,500	+1.08%	₩1.7B	₩1.5T	6.68%
Naturecell007390 · KOSDAQ	₩22,150	−0.67%	₩3.6B	₩1.4T	0.44%
OSCOTECInc039200 · KOSDAQ	₩36,650	+2.09%	₩3.1B	₩1.4T	3.87%
Aimed Bio0009K0 · KOSDAQ	₩20,850	+1.46%	₩2.4B	₩1.4T	0.03%
Kolon TissueGene950160 · KOSDAQ	₩14,600	−1.08%	₩4.9B	₩1.2T	0.57%
Ingenia Therapeutics950260 · KOSDAQ	₩23,600	+1.51%	₩5.8B	₩1.2T	—
Daewoong Pharma069620 · KOSPI	₩99,900	+0.81%	₩2.5B	₩1.2T	10.30%
Curiox Biosystems445680 · KOSDAQ	₩62,400	+0.16%	₩7.3B	₩1.1T	1.25%
Chong Kun Dang Pharmaceutical185750 · KOSPI	₩61,900	+0.98%	₩716M	₩854B	6.34%
JS Link127120 · KOSDAQ	₩18,630	+2.59%	₩3B	₩697B	5.05%
Qurient115180 · KOSDAQ	₩17,970	−2.55%	₩2.6B	₩674B	3.88%
L&C Bio290650 · KOSDAQ	₩24,950	+4.83%	₩4.8B	₩673B	1.28%
Chabiotech085660 · KOSDAQ	₩7,080	+0.71%	₩1.2B	₩658B	0.31%
Rznomics476830 · KOSDAQ	₩23,400	+3.77%	₩4B	₩656B	3.96%
G2GBIO456160 · KOSDAQ	₩37,900	−3.19%	₩26B	₩630B	2.41%
Pharmicell005690 · KOSPI	₩10,230	+4.39%	₩4.3B	₩614B	2.38%
Onconic Therapeutics476060 · KOSDAQ	₩13,070	+2.35%	₩1.2B	₩593B	—
Proteina468530 · KOSDAQ	₩51,500	+5.21%	₩10B	₩572B	3.78%
JW Pharmaceutical001060 · KOSPI	₩23,200	+0.22%	₩975M	₩570B	2.44%
Hyundai Bioscience048410 · KOSDAQ	₩5,870	+0.86%	₩7.4B	₩566B	0.37%
Medy-Tox086900 · KOSDAQ	₩65,800	−2.52%	₩903M	₩480B	1.44%
BioNote377740 · KOSPI	₩4,595	+0.88%	₩195M	₩468B	0.81%
GI Innovation358570 · KOSDAQ	₩7,140	+1.56%	₩1.3B	₩461B	4.07%
Shinpoong Pharmaceutical019170 · KOSPI	₩8,460	+1.32%	₩1.4B	₩443B	0.39%
GC005250 · KOSPI	₩9,130	+1.11%	₩384M	₩429B	5.94%
Penetrium Bioscience187660 · KOSDAQ	₩6,660	+4.88%	₩5.6B	₩426B	—
AbClon174900 · KOSDAQ	₩21,100	0.00%	₩5.5B	₩421B	3.57%
GemVax & KAEL082270 · KOSDAQ	₩9,040	+0.33%	₩1.1B	₩411B	2.55%
HLB Life Science067630 · KOSDAQ	₩3,340	−0.45%	₩481M	₩407B	0.07%
IL Dong Pharmaceutical249420 · KOSPI	₩12,790	+1.11%	₩1.2B	₩405B	2.30%
Curocell372320 · KOSDAQ	₩25,000	+2.46%	₩1.1B	₩381B	0.46%
Bukwang Pharmaceutical IND003000 · KOSPI	₩3,750	−0.13%	₩818M	₩370B	0.68%
Orum Therapeutics475830 · KOSDAQ	₩16,360	+1.80%	₩1.5B	₩356B	0.09%
AprilBio397030 · KOSDAQ	₩12,400	+0.49%	₩1.3B	₩342B	0.95%
Medipostco078160 · KOSDAQ	₩8,670	+2.12%	₩803M	₩340B	1.55%
Dong-A ST170900 · KOSPI	₩34,900	0.00%	₩337M	₩340B	4.78%
Samyang Biopharm0120G0 · KOSPI	₩41,550	−1.07%	₩1.1B	₩309B	1.73%
SillaJen215600 · KOSDAQ	₩2,120	−0.47%	₩1.1B	₩294B	0.09%
ToolGen199800 · KOSDAQ	₩29,800	+6.24%	₩854M	₩291B	0.43%
EuBiologics206650 · KOSDAQ	₩7,620	+1.60%	₩551M	₩277B	0.17%
NKGen Biotech Korea182400 · KOSDAQ	₩3,670	0.00%	₩0	₩265B	—
ImmuneOncia Therapeutics424870 · KOSDAQ	₩2,870	+1.41%	₩1.1B	₩262B	—
Genomictree228760 · KOSDAQ	₩10,400	+6.89%	₩641M	₩259B	0.51%
Q AID377460 · KOSDAQ	₩4,080	0.00%	₩0	₩253B	—
S.Biomedics304360 · KOSDAQ	₩20,150	−0.25%	₩792M	₩251B	—
FutureChem220100 · KOSDAQ	₩8,080	−4.04%	₩2.6B	₩250B	0.76%
HLB Therapeutics115450 · KOSDAQ	₩2,635	−0.57%	₩917M	₩249B	0.10%
IntoCell287840 · KOSDAQ	₩16,300	+2.00%	₩351M	₩245B	1.04%
Jetema216080 · KOSDAQ	₩5,960	−1.16%	₩479M	₩222B	0.01%
BioPlus099430 · KOSDAQ	₩3,360	+1.20%	₩275M	₩207B	0.42%
DuChemBio176750 · KOSDAQ	₩7,160	+1.70%	₩2.2B	₩204B	0.04%
Genome&Company314130 · KOSDAQ	₩3,840	−1.54%	₩1B	₩201B	0.24%
GC Genome340450 · KOSDAQ	₩8,440	+1.20%	₩6.7B	₩200B	—
Binex053030 · KOSDAQ	₩6,100	+0.49%	₩379M	₩199B	2.17%
3billion394800 · KOSDAQ	₩6,200	+11.11%	₩6.7B	₩197B	4.02%
HEM Pharma376270 · KOSDAQ	₩27,100	−4.07%	₩339M	₩196B	—
Bioneercorporation064550 · KOSDAQ	₩7,070	0.00%	₩1.1B	₩182B	0.10%
curacle365270 · KOSDAQ	₩8,210	+3.53%	₩294M	₩182B	0.50%
Vivozon Pharmaceutical082800 · KOSDAQ	₩2,915	−1.52%	₩279M	₩177B	—
Kangstem Biotech217730 · KOSDAQ	₩1,863	−0.11%	₩387M	₩175B	0.10%
Helixmith084990 · KOSDAQ	₩3,730	−2.10%	₩938M	₩172B	0.12%
BNC Korea256840 · KOSDAQ	₩2,485	+0.40%	₩1B	₩170B	—
Kolon Life Science102940 · KOSDAQ	₩12,940	+1.41%	₩608M	₩169B	0.50%
Eone Diagnomics Genome Center245620 · KOSDAQ	₩741	0.00%	₩0	₩167B	—
GC Cell144510 · KOSDAQ	₩10,470	−19.15%	₩3.7B	₩165B	0.06%
Aptabio Therapeutics293780 · KOSDAQ	₩5,490	−8.96%	₩920M	₩154B	0.05%
Cellbion308430 · KOSDAQ	₩11,940	+5.48%	₩281M	₩154B	—
ISU Abxis086890 · KOSDAQ	₩3,595	+1.70%	₩232M	₩147B	0.20%
Bio Solution086820 · KOSDAQ	₩5,590	−1.06%	₩322M	₩145B	0.15%
Y-Biologics338840 · KOSDAQ	₩9,390	−7.94%	₩890M	₩145B	0.17%
Aribio Holdings290690 · KOSDAQ	₩2,700	−1.28%	₩650M	₩143B	—
Anterogen065660 · KOSDAQ	₩13,960	−0.14%	₩248M	₩140B	0.30%
Cell Biotech049960 · KOSDAQ	₩14,830	−0.54%	₩53M	₩139B	0.00%
Kanaph Therapeutics0082N0 · KOSDAQ	₩10,030	+2.24%	₩866M	₩133B	—
JW Shinyak067290 · KOSDAQ	₩2,375	+0.64%	₩2.7B	₩133B	—
Ensol Biosciences140610 · KONEX	₩8,920	+7.21%	₩27M	₩128B	—
Pharmaresearch Bio217950 · KONEX	₩29,200	−0.17%	₩691,600	₩122B	—
Macrogen038290 · KOSDAQ	₩11,240	+1.72%	₩103M	₩122B	4.56%
TiumBio321550 · KOSDAQ	₩3,835	−1.79%	₩729M	₩115B	0.31%
Keeps Biopharma256940 · KOSDAQ	₩5,510	+0.36%	₩83M	₩111B	—
ViGenCell308080 · KOSDAQ	₩5,040	−0.59%	₩512M	₩103B	0.59%
Celemics331920 · KOSDAQ	₩9,230	+0.11%	₩99M	₩103B	—
HLB bioStep278650 · KOSDAQ	₩5,910	−5.89%	₩2.5B	₩103B	—
Genexine095700 · KOSDAQ	₩2,250	−3.23%	₩437M	₩102B	0.15%
MedPacto235980 · KOSDAQ	₩2,925	−2.99%	₩254M	₩100B	2.96%
Asta246720 · KOSDAQ	₩6,070	0.00%	₩0	₩99B	—
Metabiomed059210 · KOSDAQ	₩3,635	−0.68%	₩624M	₩99B	—
Aribiolab261780 · KOSDAQ	₩3,405	+0.15%	₩629M	₩99B	—
CHA AI Healthkare025620 · KOSPI	₩5,300	−0.93%	₩30M	₩96B	0.01%
DreamCIS223250 · KOSDAQ	₩3,870	−2.15%	₩960M	₩95B	—
iNtRON Biotechnology048530 · KOSDAQ	₩3,045	−0.16%	₩437M	₩94B	1.38%
Vaxcell-Bio Therapeutics323990 · KOSDAQ	₩3,955	−0.25%	₩495M	₩92B	0.07%
T&R Biofab246710 · KOSDAQ	₩1,906	−1.75%	₩189M	₩91B	0.95%
Corestemchemon166480 · KOSDAQ	₩1,705	+2.46%	₩236M	₩90B	0.02%
Aminologics074430 · KOSDAQ	₩1,007	+0.70%	₩76M	₩90B	—
HLB Global003580 · KOSPI	₩1,772	−2.96%	₩673M	₩90B	0.29%
Enzychem Lifesciences183490 · KOSDAQ	₩990	0.00%	₩0	₩84B	0.30%
Choong ANG Vaccine Laboratory072020 · KOSDAQ	₩8,830	+0.57%	₩32M	₩82B	—
Pharos iBio388870 · KOSDAQ	₩5,890	+1.38%	₩126M	₩76B	—
HLB Genex187420 · KOSDAQ	₩2,300	+3.14%	₩260M	₩75B	—
Polaris AI Pharma041910 · KOSDAQ	₩5,640	+1.99%	₩145M	₩75B	—
Yuhan Pref.000105 · KOSPI	₩65,200	0.00%	₩66M	₩75B	—
SCL Science246960 · KOSDAQ	₩2,135	−6.97%	₩634M	₩74B	—
Eye Gene185490 · KOSDAQ	₩1,717	−1.83%	₩339M	₩74B	2.40%
Theragen Etex066700 · KOSDAQ	₩2,020	−0.25%	₩53M	₩74B	0.40%
DongKook Life Science303810 · KOSDAQ	₩2,275	−0.22%	₩309M	₩73B	—
Choolip & Sciences291650 · KOSDAQ	₩2,310	−3.14%	₩91M	₩71B	—
Inventera0007J0 · KOSDAQ	₩8,830	+2.32%	₩339M	₩69B	—
SunBio067370 · KOSDAQ	₩5,680	+1.07%	₩17M	₩69B	—
Sugentech253840 · KOSDAQ	₩4,105	+0.61%	₩150M	₩69B	—
Naturalendo Tech168330 · KOSDAQ	₩2,095	+0.24%	₩8.7M	₩67B	0.10%
CTC Bio060590 · KOSDAQ	₩2,685	−1.29%	₩85M	₩65B	—
Amicogen092040 · KOSDAQ	₩915	0.00%	₩244M	₩65B	0.37%
Optipharm153710 · KOSDAQ	₩4,375	+0.57%	₩70M	₩64B	0.44%
Pangen Biotech222110 · KOSDAQ	₩4,640	+1.31%	₩24M	₩63B	—
PharmGen Science004720 · KOSPI	₩2,740	−0.36%	₩91M	₩62B	0.08%
Abion203400 · KOSDAQ	₩3,380	0.00%	₩0	₩61B	0.98%
Cellid299660 · KOSDAQ	₩2,040	−4.00%	₩651M	₩60B	0.02%
Tego Science191420 · KOSDAQ	₩7,400	+6.32%	₩57M	₩60B	—
Adbiotech179530 · KOSDAQ	₩1,909	−3.73%	₩89M	₩59B	—
HLB Panagene046210 · KOSDAQ	₩1,300	+1.09%	₩158M	₩59B	—
NeoImmuneTech950220 · KOSDAQ	₩1,677	+0.42%	₩209M	₩57B	—
Cytogen217330 · KOSDAQ	₩2,475	+1.02%	₩138M	₩57B	—
Imgt456570 · KONEX	₩10,630	−1.57%	₩16M	₩56B	—
HL Genomics0156T0 · KOSDAQ	₩7,150	+0.42%	₩225M	₩56B	—
ENCell456070 · KOSDAQ	₩5,030	+9.59%	₩5.2B	₩55B	—
KoBioLabs348150 · KOSDAQ	₩2,720	−1.09%	₩31M	₩53B	—
Geninus389030 · KOSDAQ	₩1,305	−2.25%	₩651M	₩51B	—
QuadMedicine464490 · KOSDAQ	₩4,365	+6.72%	₩352M	₩50B	—
Aprogen007460 · KOSPI	₩1,940	+1.36%	₩746M	₩50B	0.76%
GeneOne Life Science011000 · KOSPI	₩2,670	0.00%	₩0	₩49B	0.19%
Epi Biotech446440 · KONEX	₩21,000	−4.33%	₩231,000	₩48B	—
CJ Bioscience311690 · KOSDAQ	₩3,650	+0.27%	₩9.2M	₩48B	—
RPbio314140 · KOSDAQ	₩5,300	+0.57%	₩18M	₩46B	—
Gencurix229000 · KOSDAQ	₩1,957	0.00%	₩0	₩46B	0.81%
NovMetaPharma229500 · KONEX	₩3,455	+2.07%	₩81M	₩45B	—
Quratis348080 · KOSDAQ	₩3,495	+2.79%	₩56M	₩45B	—
Oncocross382150 · KOSDAQ	₩3,145	+1.13%	₩64M	₩41B	—
Wonbiogen307280 · KOSDAQ	₩5,760	+1.05%	₩163M	₩41B	—
HLB Pep196300 · KOSDAQ	₩4,100	−1.09%	₩44M	₩39B	—
Organoidsciences476040 · KOSDAQ	₩5,900	+0.85%	₩65M	₩39B	1.38%
Orientbio002630 · KOSPI	₩1,288	−0.69%	₩30M	₩38B	0.06%
Kolmar BioTech215380 · KOSDAQ	₩2,140	+1.90%	₩90M	₩36B	—
Kainos Medicine284620 · KOSDAQ	₩1,087	0.00%	₩0	₩36B	—
IMBdx461030 · KOSDAQ	₩2,475	−1.39%	₩35M	₩35B	0.31%
Eutilex263050 · KOSDAQ	₩959	0.00%	₩0	₩35B	0.74%
Aligned Genetics238120 · KOSDAQ	₩2,440	+0.21%	₩53M	₩35B	—
SeouLin Bioscience038070 · KOSDAQ	₩3,670	+1.24%	₩33M	₩34B	—
Hass450330 · KOSDAQ	₩4,125	+0.73%	₩6.9M	₩34B	—
Biotoxtech086040 · KOSDAQ	₩2,110	+1.44%	₩19M	₩34B	—
Genolution225220 · KOSDAQ	₩1,717	+0.35%	₩61M	₩33B	—
Linkgenesis219420 · KOSDAQ	₩2,830	+1.07%	₩34M	₩32B	—
ProGen296160 · KONEX	₩2,100	+1.94%	₩1.9M	₩32B	—
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ	₩1,969	0.00%	₩0	₩30B	—
LabGenomics084650 · KOSDAQ	₩2,015	+8.92%	₩273M	₩30B	0.58%
Genematrix109820 · KOSDAQ	₩1,432	−1.24%	₩26M	₩29B	—
Dt&Cro383930 · KOSDAQ	₩2,000	−1.48%	₩102M	₩26B	—
C&R Research359090 · KOSDAQ	₩2,205	+1.38%	₩16M	₩25B	—
GFC Life Science388610 · KOSDAQ	₩4,480	−1.43%	₩211M	₩24B	—
Shaperon378800 · KOSDAQ	₩2,350	+0.21%	₩38M	₩22B	—
Daesung Microbiological Labs036480 · KOSDAQ	₩5,520	+0.55%	₩8M	₩21B	—
Enbioco352940 · KOSDAQ	₩1,901	−1.55%	₩9.9M	₩21B	—
MFC432980 · KOSDAQ	₩2,275	−5.01%	₩12M	₩20B	—
WooGene B&Gco018620 · KOSDAQ	₩2,770	−1.95%	₩74M	₩19B	—
Plumbline Life Sciences222670 · KONEX	₩4,635	0.00%	₩0	₩19B	—
Moogene Medi322970 · KONEX	₩1,810	−0.55%	₩267,125	₩18B	—
Xcell Therapeutics373110 · KOSDAQ	₩1,040	+3.07%	₩47M	₩18B	—
PCL241820 · KOSDAQ	₩6,040	0.00%	₩0	₩17B	—
Kbio Labs038530 · KOSDAQ	₩3,105	+1.31%	₩21M	₩16B	—
PeopleBio304840 · KOSDAQ	₩561	0.00%	₩0	₩14B	—
Celestra352770 · KOSDAQ	₩5,250	0.00%	₩0	₩14B	—
Olipass244460 · KOSDAQ	₩1,651	0.00%	₩0	₩13B	—
Curachem456190 · KONEX	₩7,210	0.00%	₩0	₩13B	—
From Bio377220 · KOSDAQ	₩1,909	−1.04%	₩171M	₩11B	—
NGeneBio354200 · KOSDAQ	₩665	−2.35%	₩278M	₩11B	—
Invites Biocore216400 · KONEX	₩1,360	−2.79%	₩167,554	₩10B	—
Median Diagnostics233250 · KONEX	₩4,800	0.00%	₩0	₩8.4B	—
BioInfra199730 · KOSDAQ	₩1,640	+2.44%	₩166M	₩8B	—
Phionx900100 · KOSDAQ	₩1,155	−14.44%	₩88M	₩6.1B	—
Medizen Humancare236340 · KONEX	₩1,350	+3.85%	₩191,200	₩4.1B	—
Cronex215570 · KONEX	₩600	−12.41%	₩634,595	₩4B	—
BioInfra Life Science266470 · KONEX	₩99	+4.21%	₩180,195	₩2.8B	—

Source: KRX statistical information